Screening for prostate cancer by PSA determination: a time for caution

被引：6

作者：

Ciatto, S ^{[1
]}

机构：

[1] Azienda Osped Careggi, Ctr Studio Prevenz Oncol, I-50131 Florence, Italy

来源：

关键词：

D O I：

10.1177/172460080001500401

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

引用

页码：285 / 287

页数：3

共 15 条

[1] Advisory Comm Canc Prevention, 2000, EUR J CANCER, V36, P1473
[2] AUVINEN A, 1996, EUROPEAN RANDOMISED, P167
[3] Prostate cancer screening: the problem of overdiagnosis and lessons to be learned from breast cancer screening
Ciatto, S
Zappa, M
Bonardi, R
Gervasi, G
[J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (11) : 1347 - 1350
[4] Screening for cancer: Future potential
Cuzick, J
[J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 (05) : 685 - 692
[5] LATENT PROSTATIC-CANCER IN A CONSECUTIVE AUTOPSY SERIES
HOLUND, B
[J]. SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1980, 14 (01): : 29 - 35
[6] HIGH 10-YEAR SURVIVAL RATE IN PATIENTS WITH EARLY, UNTREATED PROSTATIC-CANCER
JOHANSSON, JE
ADAMI, HO
ANDERSSON, SO
BERGSTROM, R
HOLMBERG, L
KRUSEMO, UB
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (16): : 2191 - 2196
[7] Labrie F, 2000, PROSTATE, V43, P215, DOI 10.1002/(SICI)1097-0045(20000515)43:3<215::AID-PROS7>3.0.CO
[8] 2-G
[9] Mettlin C, 1996, CANCER, V77, P150, DOI 10.1002/(SICI)1097-0142(19960101)77:1<150::AID-CNCR25>3.3.CO
[10] 2-M